SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001824293-23-000130
Filing Date
2023-05-26
Accepted
2023-05-26 16:16:22
Documents
4
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2023proxystatement.htm DEF 14A 549285
2 GRAPHIC gribioinc_vxprxyxgt20xp961.jpg GRAPHIC 410612
3 GRAPHIC gribioinc_vxprxyxgt20xp961a.jpg GRAPHIC 210387
4 GRAPHIC grilogo.jpg GRAPHIC 16794
  Complete submission text file 0001824293-23-000130.txt   1428483
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40034 | Film No.: 23969112
SIC: 2834 Pharmaceutical Preparations